Austin Miller

Roswell Park Comprehensive Cancer Center

Also affiliated with University of Victoria

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.870Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017

Top 23%

0.870DataRank

Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Papers

Driven by 17 papers — median percentile 77. Top paper: “Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial”.

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02011

N/A

2.6DataRank · unranked

88 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +16 more

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.018

N/A

0.908DataRank · unranked

28 citations

Michael A. Bookman, Jalid Sehouli, Austin Miller, Richard T. Penson, Çağatay Taşkıran +20 more

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017

Top 23%

0.870DataRank

Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279

Journal of Clinical Oncology(2024)10.1200/jco.23.02235

N/A

0.637DataRank · unranked

19 citations

Wei Deng, I. Peterson, Robert S. Mannel, J. S. Thompson, Elizabeth Lokich +12 more

A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6003

N/A

0.606DataRank · unranked

56 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +15 more

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.021

N/A

0.241DataRank · unranked

4 citations

Austin Miller, Robert A. Soslow, Heather A. Lankes, Deborah F. DeLair, Sheila Segura +10 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.015

N/A

0DataRank · unranked

25 citations

Lari Wenzel, Chelsea McKinney, Lynne I. Wagner, David Cella, Giulia Fulci +10 more

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3877

N/A

0DataRank · unranked

8 citations

Austin Miller, Peter G. Rose, Mariam AlHilli, Christina Washington, Veena S. John +15 more

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability

Cancers(2020)10.3390/cancers12030764

N/A

0DataRank · unranked

146 citations

David Klinkebiel, Carter J. Barger, Sanjit Pandey, Chittibabu Guda, Austin Miller +4 more

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3042

N/A

0DataRank · unranked

2 citations

Austin Miller, Heather A. Lankes, Kwong‐Kwok Wong, William H. Rodgers, David Millan +20 more

A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.06.071

N/A

0DataRank · unranked

20 citations

Austin Miller, Ana Medina-Palomo, Casey W. Williamson, Hannah Nguyen, Jessica Lowenstein +9 more

Development and Evaluation of an Accelerometer-Based Protocol for Measuring Physical Activity Levels in Cancer Survivors: Development and Usability Study

JMIR mhealth and uhealth(2020)10.2196/18491

N/A

0DataRank · unranked

16 citations

Meghan B. Skiba, Austin Miller, David O. Garcia, Cynthia A. Thomson, Tracy E. Crane

Global DNA hypomethylation in epithelial ovarian cancer: passive demethylation and association with genomic instability

medRxiv(2020)10.1101/2020.01.22.20018374

N/A

0DataRank · unranked

207 citations

David Klinkebiel, Carter J. Barger, Sanjit Pandey, Chittibabu Guda, Austin Miller +4 more

Association of chronotype and pain at baseline in ovarian cancer survivors participating in a lifestyle intervention (NRG/GOG 0225).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6018

N/A

0DataRank · unranked

0 citations

Austin Miller, Meghan B. Skiba, Sidney M. Donzella, Cynthia A. Thomson, Tracy E. Crane

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

UNC Libraries(2020)10.17615/dy70-ej71

N/A

0DataRank · unranked

0 citations

Kay‐Tee Khaw, Mark E. Robson, Diether Lambrechts, Janna Lilyquist, Emily Hallberg +95 more

A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5601

N/A

0DataRank · unranked

11 citations

Lilian T. Gien, Austin Miller, Al Covens, David M. Gershenson, Amanda N. Fader

Austin Miller

Indexed papers

Top data-sharing exemplar

Papers